TOP1 and breast carcinoma: Moreover, camptothecin targets the nuclear enzyme topoisomerase I (TOP1) to treat endocrine-resistant breast cancer (55), and embelin is capable of inducing apoptosis in MCF-7 breast cancer cells (56).